Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
THC Biomed INTL ( (TSE:THC) ) has shared an update.
THC BioMed Intl Ltd. announced the sale of two strata units from its Kelowna facility for $750,000, with the transaction expected to close on February 14, 2025. The proceeds will be used to cover transaction expenses and provide working capital, indicating a strategic move to optimize financial management and support operational goals.
More about THC Biomed INTL
THC BioMed is a leading Canadian cannabis producer focused on delivering high-quality cannabis products nationwide. The company emphasizes innovation, sustainability, and customer satisfaction, and aims to set new standards in the cannabis industry through its commitment to excellence.
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $2.29M
For detailed information about THC stock, go to TipRanks’ Stock Analysis page.
